]>
IRCT20110527006611N3 IRCT 2019-11-12 Kermanshah University of Medical Sciences Comparison the Effect of Interval, Continuous and combined Aerobic Exercise on Liver Enzymes and Metabolic Syndrome in Overweight Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Comparison the Effect of Interval, Continuous and combined Aerobic Exercise on Liver Enzymes, IGF-1 and Insulin Hormone and Metabolic Syndrome in Overweight Type 2 Diabetic Patients with Nonalcoholic Fatty Liver 2018-10-23 anticipated 48 Complete https://irct.ir/trial/40902 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Patients were classified according to fatty liver grade and then randomly divided into 4 groups. N/A Type 2 diabetes- Non-alcoholic fatty liver disease. Intervention 1: Intervention group: interval aerobic exercise - The interval aerobic exercise group performed exercise on a stationary bike for two months, three days a week, with an intensity of 75 to 80 percent of maximum heart rate. Intervention 2: Intervention group: Continuous aerobic exercise - The Continuous aerobic exercise group performed exercise on a stationary bike for two months, three days a week, with an intensity of 60 to 75 percent of maximum heart rate. Intervention 3: Intervention group: Combined aerobic exercise - The combined aerobic exercise group performed exercise on a stationary bike for two months, three days a week, and in between sessions (continuous aerobic exercise and periodic aerobic exercise). Intervention 4: Control group: No regular exercise. Yes - There is a plan to make this available What will be shared: The informed consent form will be available to others without mentioning the names of the participants. Details of the study process are also provided in detail in the file format. When: Start of the 8 month period after the research To whom: For university students and students in research related fields Conditions: There are no specific conditions to provide such information. Where to obtain: Zahra Bayat How to obtain: Send message to the person responsible for providing the data Comments:
public Zahra Bayat
Kish International Campus, University of Tehran, Niyayesh St., Mirmohanna Blvd., Kish Island, Iran.
kish Iran (Islamic Republic of) 79416-55665 00987644433661-2 z.bayat@ut.ac.ir The University of Tehran scientific Reza Nuri
Kish International Campus, University of Tehran, Niyayesh St., Mirmohanna Blvd., Kish Island, Iran
kish Iran (Islamic Republic of) 79416-55665 00987644433661-2 nuri_r7@ut.ac.ir University of Tehran Iran (Islamic Republic of) Subjects are type 2 diabetic women with non-alcoholic fatty liver. They are non-insulin-dependent They use oral medications for treatment (glibenclamide and metformin and sulfonylurease). The maximum blood glycosylated hemoglobin is 11%. The minimum history of diabetes is 1 year and the maximum history of diabetes is 15 years 40 years 55 years Female Patients have retinopathy, nephropathy and severe neuropathy. Have a history of cardiovascular disease and musculoskeletal disorders Severe musculoskeletal problems that restrict physical activity E11-K76.0 K76.0: Nonalcoholic fatty liver disease [NAFLD]-E11: Type 2 diabetes mellitus Lifestyle Lifestyle Lifestyle Other Intervention group: interval aerobic exercise - The interval aerobic exercise group performed exercise on a stationary bike for two months, three days a week, with an intensity of 75 to 80 percent of maximum heart rate. Intervention group: Continuous aerobic exercise - The Continuous aerobic exercise group performed exercise on a stationary bike for two months, three days a week, with an intensity of 60 to 75 percent of maximum heart rate. Intervention group: Combined aerobic exercise - The combined aerobic exercise group performed exercise on a stationary bike for two months, three days a week, and in between sessions (continuous aerobic exercise and periodic aerobic exercise). Control group: No regular exercise Alanine Aminotransferase enzyme. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. Aspartate Aminotransferase enzyme. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. Alkaline phosphatase enzyme. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. Glycosylated hemoglobin. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with Pishtaz Teb kit. HDL Cholesterol. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. LDL Cholesterol. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. Cholesterol. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. Triglyceride. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. Waist circumference. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Standard tape meter. Blood Pressure. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: brachial digital blood pressure monitor. Fasting blood glucose. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit. IGF-1 Hormone. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with DiaSorin kit. University of Tehran Approved 2018-10-08 Ethics Committee of Sport Sciences Research Institute No. 3, 5th Alley, Miremad Street, Motahhari Street, tehran Tehran Iran (Islamic Republic of)